Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have symptoms that could suggest bowel cancer, such as rectal bleeding lasting a week or more
- People who are attending a routine bowel cancer screening colonoscopy
- People who have received a confirmed diagnosis of bowel cancer through a colonoscopy or surgical sample within the past 3 weeks
- People whose colonoscopy showed non-cancerous growths called adenomatous polyps, within the past 3 weeks
- People whose colonoscopy showed no abnormal findings, within the past 3 weeks
- People aged 18 or older
- People who are willing to take part in the study
Who may not be able to join:
- No specific exclusion criteria were listed in the source information (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Peter Kingham, MD, Memorial Sloan Kettering Cancer Center
Phone: 212-639-5260
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sensitivity of 3-metabolite biosensor
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.